Eye drops for dry eye from gland dysfunction
Part of Eyes & vision clinical trials.
This trial tests if a new eye drop (perfluorohexyloctane) is safe and effective for treating dry eye caused by meibomian gland dysfunction (a common condition where the oil glands in your eyelids don't work properly). It may help if you have this type of dry eye and are looking for a new option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with meibomian gland dysfunction (a problem with oil glands in your eyelids).
- You have been diagnosed with dry eye disease.
- You are 18 years old or older.
- You agree to take part and sign a consent form.
- You have not used perfluorohexyloctane eye drops in the past 2 weeks.
- You are not in another drug or device trial currently or within the past month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new eye drop gel (CsA-PG) for people with dry eye disease. Participants must have had dry eyes for at least 6 months and meet specific eye exam scores. The study checks if the gel can improve symptoms and eye health.
This trial compares two different dry-eye eye drops to see which works better and is safe. You may be able to join if you’ve had dry eye for at least 3 months and meet specific eye-test results.
This trial studies whether BUFY01 eye drops work better than SVS20 for treating dry eye disease. You may be able to join if you have dry eye symptoms for at least 3 months and meet eye exam score and tear-test requirements.
This trial tests two different types of eye drops for people with dry eyes that are linked to lots of screen time. It compares a new eye drop (perfluorohexyloctane) to a common one (sodium hyaluronate) to see which works better for screen-related dry eye.
This study tests if a new eye drop works as well as two others for people with moderate to severe evaporative dry eye, a common type caused by tear evaporation. It aims to find a better treatment option for managing symptoms.
This study tests whether TearCare, a device that warms and massages the eyelids, can help young adults with dry eyes caused by blocked oil glands. The trial measures whether the treatment improves tear quality and eye comfort.
Hear when a new Dry Eye Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.